Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics

This page shows the latest Crescendo Biologics news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

Our highly productive relationship draws together Takeda’s deep oncology experience with Crescendo’s expertise in developing optimally configured Humabodies. ... Together we are fast progressing towards our goal of developing next generation, highly

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    PME talks to CEO Theodora Harold. In this October’s issue of PME, we take an in-depth look at Crescendo Biologics and talk to CEO Theodora Harold (pictured above) about ... The company is based in Cambridge, UK, which is renowned for its antibody and

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    That’s why Theodora Hall taking on the top job at emerging UK biotech Crescendo Biologics is worth noting, as she represents a new generation of leaders in the sector. ... She played a key role in Crescendo’s recent $70m fundraising project, has

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’ CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    For example, in October, Takeda announced a cancer collaboration with Crescendo Biologics, which could be worth nearly $800m to the Cambridge-based biotech.

More from intelligence
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest appointments

  • New hires at Crescendo, Healx and Galecto New hires at Crescendo, Healx and Galecto

    The latest movers in pharma. Crescendo. Crescendo Biologics has appointed Kenji Hashimoto as its new chief medical officer, who joins Crescendo with over 15 years of experience in oncology and ... Kenji has considerable immuno-oncology expertise and an

  • Crescendo Biologics appoints Edward Stewart as chief business officer Crescendo Biologics appoints Edward Stewart as chief business officer

    He joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals. Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer. ... Peter Pack, CEO of Crescendo Biologics, said: “A strong and

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    Theodora Harold joins the drug discovery firm. Cambridge, UK-based Crescendo Biologics has appointed Theodora Harold as its new chief financial officer. ... Dr Peter Pack, chief executive officer of Crescendo Biologics, said: “Theo's appointment as

  • C4X Discovery appoints chief executive officer C4X Discovery appoints chief executive officer

    Since joining GlaxoSmithKline's research department in 1988, Dix has held a series of senior leadership positions including chief executive officer of Convergence Pharmaceuticals and chairman of both Crescendo Biologics and

  • Crescendo Biologics appoints Dr Kevin Johnson as chairman Crescendo Biologics appoints Dr Kevin Johnson as chairman

    Brings Cambridge, UKfirm experience from Pangenetics. Cambridge, UK-based biopharmaceutical company Crescendo Biologics has appointed Dr Kevin Johnson as non-executive chairman of the board of directors. ... He said: “Crescendo Biologics has a very

More from appointments
Approximately 4 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020
...
1000 Voices Survey
The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went...
COVID-19 vaccine
How will COVID-19 affect uptake of vaccinations against other diseases?
Will COVID-19 help or hinder the quest to increase uptake of other vaccinations?...

Infographics